Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00083986" target="_blank" >RIV/00216224:14110/15:00083986 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00159816:_____/15:00063574

Výsledek na webu

<a href="http://dx.doi.org/10.1111/jdv.12772" target="_blank" >http://dx.doi.org/10.1111/jdv.12772</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/jdv.12772" target="_blank" >10.1111/jdv.12772</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Popis výsledku v původním jazyce

Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal.Due to its rarity, only few prospective controlled therapeutic trials are available. Objectives:For this reason, a group of European dermatologists with a long-standing interest and expertise in basic and clinical pemphigus research has sought to definediagnostic and therapeutic guidelines for the management of patients with pemphigus. Results:This group identified the statements of major agreement or disagreement regarding the diagnostic and therapeutic management of pemphigus. The revised final version of the pemphigus guideline was finally passed on to the European Dermatology Forum (EDF) for a final consensus with the European Academy of Dermatology and Venereology (EADV) and the European Union of Medical Specialists (UEMS).

Název v anglickém jazyce

Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Popis výsledku anglicky

Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal.Due to its rarity, only few prospective controlled therapeutic trials are available. Objectives:For this reason, a group of European dermatologists with a long-standing interest and expertise in basic and clinical pemphigus research has sought to definediagnostic and therapeutic guidelines for the management of patients with pemphigus. Results:This group identified the statements of major agreement or disagreement regarding the diagnostic and therapeutic management of pemphigus. The revised final version of the pemphigus guideline was finally passed on to the European Dermatology Forum (EDF) for a final consensus with the European Academy of Dermatology and Venereology (EADV) and the European Union of Medical Specialists (UEMS).

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of the European Academy of Dermatology and Venereology

ISSN

0926-9959

e-ISSN

—

Svazek periodika

29

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

10

Strana od-do

405-414

Kód UT WoS článku

000350039500001

EID výsledku v databázi Scopus

—